First National Bank of Omaha’s PDL BioPharma, Inc. PDLI Stock Holding History

First National Bank of Omaha’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-59,505	Closed	-$495K	–	407
2014 Q1	$495K	Buy	59,505 +1,140	+2%	+$9.77K	0.04%	302
2013 Q4	$492K	Sell	58,365 -1,100	-2%	-$9.27K	0.04%	289
2013 Q3	$474K	Buy	59,465 +10,100	+20%	+$81.2K	0.04%	285
2013 Q2	$381	Buy	+49,365	New	+$385K	0.03%	309

Other funds holding PDLI

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First National Bank of Omaha's PDLI Position: Q2 2014 in Review

First National Bank of Omaha sold out of PDL BioPharma, Inc. (PDLI) in Q2 2014, closing a stake of 59,505 shares — an estimated $495K sold.

First National Bank of Omaha first reported a position in PDLI in Q2 2013 and held it in 4 quarters. The position peaked at $495K in Q1 2014. 222 funds tracked by Wall St. Rank hold PDLI as of Q2 2014.

First National Bank of Omaha reported no remaining PDL BioPharma, Inc. position as of Q2 2014 after selling out during the quarter.
First National Bank of Omaha sold 59,505 PDL BioPharma, Inc. shares in Q2 2014, an estimated $495K.
First National Bank of Omaha first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 4 quarters.
First National Bank of Omaha's PDL BioPharma, Inc. position peaked at $495K in Q1 2014.
222 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2014.

Based on First National Bank of Omaha's 13F filing for Q2 2014, filed 11 Aug 2014.